Market Estimation Report of China’s coronary balloon dilator Catheter market （2023）

01 Product brief introduction

1. Product classification

According to the 2017 Classification Catalog of Medical Devices issued by the NMPA, the coronary balloon dilation catheter belongs to the third category of nerve and cardiovascular surgical instruments, and the management category is III.

On the track, coronary balloon dilator catheter belongs to the field of medical consumables – high value consumables -C02 vascular interventional therapy materials – cardiovascular interventional consumables.

2. Application area

Coronary heart disease is the second largest cardiovascular disease in China. Percutaneous coronary intervention (PCI) is currently the main means of treating coronary heart disease in China. As an important instrument of PCI, coronary balloon dilation catheter covers the main treatment process of PCI, including coronary balloon and coronary drug balloon, etc.

02 Driving factor

1.Policy factor

The 14th Five-Year Plan for the Development of Medical Equipment Industry is the first national plan for the development of the medical equipment industry in China. It covers the requirements for prevention, diagnosis, treatment to health, care and maintenance of all-round life-cycle medical and health services. Coronary balloon dilator catheter, as a high-value consumable for cardiovascular intervention, plays the most important role in the treatment of coronary heart disease. It is a key product in the 14th Five-Year Plan.

2. Social factor

Although PCI is relatively mature in China, China has a large population base, a large number of patients with coronary heart disease, and the penetration rate of surgery is still significantly insufficient. According to the statistics of China’s Cardiovascular Quality Control Report, the number of people who undergo PCI surgery per million adults in China is about 980, only one third of that in the United States and other developed countries, and there is still a large market space.

3. Technical factor

The development of PCI in China has experienced the process of metal stent-drug-coated stent-total degradation stent. According to authoritative statistics, the proportion of drug balloon in PCI in China increased from 6.4% in 2019 to 15% in 2021, and the proportion of stent operation decreased year by year, and the growth rate of drug balloon market was much higher than other stents.

03 Market scale

1. Calculation logic

Determining the scope of application：By analyzing the application range and indications of coronary balloon dilator catheter, the corresponding diseases and treatment methods are determined.

Determining the volume of procedures: Determining the volume of PCI procedures in the country from publicly available information, and splitting and trend extrapolation with the main treatments of PCI (stents and balloons).

Determining product prices: The Joinchain MDCLOUD determines the percentage of use and price of each type of coronary balloon dilatation catheter, and extrapolates future product price trends through its price changes.

Measuring market size: based on the volume of surgery and product price, calculate the market size of coronary balloon catheter.

2. Data foundation

(1) Online purchase data

The data range was the net hanging and purchase price of coronary balloon dilator catheter from 2019 to 2021.

(2)  The authoritative Voice

It mainly includes the reported surgical volume data of the National Cardiovascular Center and other authoritative institutions and the statistical data of the Health Commission.

3. Market size forecasting

By calculating the market size of coronary balloon dilatation catheter from 2019 to 2021, and based on the proportion of PCI operations and various PCI surgical treatments, the growth rate of balloon’s proportion in PCI was deduced. It is predicted that the market size of coronary balloon dilatation catheter in China will reach 6.528 billion yuan in 2025.

Figure 1 .Market size of coronary balloon dilator catheter in China from 2019 to 2025E

4. Market Pattern

It is estimated that in 2021, China’s market share of coronary drug balloon reached 61.18%. With the further development of collection, the market price of drug balloon will decrease, which may make the usage of drug balloon get a greater increase and the market share further increase.

图2. 2021 Domestic market share of implant pacemaker in China.

China is encouraging China end uses for more domestic products in latest years. Thus, more and more overseas manufacturers are planning localization in China. BradyKnows localization team has extensive experiences in facility establishment, audit, supplier evaluation, manufacturing, registration, and marketing in China. Pls feel free to let us know any questions on China entry via info@bradyknowsmedical.com

Source：Joinchain Digital Science,  Joinchain Medical Device

Translated & edited ： Bradyknows